Literature DB >> 18066916

The role of message framing in promoting MMR vaccination: evidence of a loss-frame advantage.

Purva Abhyankar1, Daryl B O'Connor, Rebecca Lawton.   

Abstract

This study examined the effects of message framing on intentions to obtain the measles, mumps and rubella (MMR) vaccine for one's child and investigated whether Theory of Planned Behaviour (TPB) and perceived outcome efficacy variables mediate and/or moderate message framing effects. One hundred and forty women read either a loss-framed or gain-framed message and then completed measures assessing their intentions to obtain the MMR vaccine for their child, and TPB and outcome efficacy variables. Exposure to the loss frame increased intentions to obtain the MMR vaccine and influenced perceptions of outcome efficacy. This suggests that outcome efficacy, but not other TPB variables may mediate framing effects within the context of MMR vaccination. Message frame, in addition to TPB variables, significantly predicted unique variance in behavioural intentions. These findings are discussed within the context of Prospect Theory, perceived risk and prevention/detection behaviours.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18066916     DOI: 10.1080/13548500701235732

Source DB:  PubMed          Journal:  Psychol Health Med        ISSN: 1354-8506            Impact factor:   2.423


  34 in total

1.  Irish mothers' intentions to have daughters receive the HPV vaccine.

Authors:  A Fahy; D M Desmond
Journal:  Ir J Med Sci       Date:  2010-06-29       Impact factor: 1.568

2.  Behavioral economics: the key to closing the gap on maternal, newborn and child survival for Millennium Development Goals 4 and 5?

Authors:  Alison M Buttenheim; David A Asch
Journal:  Matern Child Health J       Date:  2013-05

3.  Reactions to framing of cessation messages: insights from dual-smoker couples.

Authors:  Isaac M Lipkus; Krista W Ranby; Megan A Lewis; Benjamin Toll
Journal:  Nicotine Tob Res       Date:  2013-08-13       Impact factor: 4.244

4.  Influenza vaccination acceptance among diverse pregnant women and its impact on infant immunization.

Authors:  Paula M Frew; Siyu Zhang; Diane S Saint-Victor; Ashley C Schade; Samantha Benedict; Maral Banan; Xiang Ren; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2013-10-30       Impact factor: 3.452

5.  The use of message framing to promote sexual risk reduction in young adolescents: a pilot exploratory study.

Authors:  Deepa R Camenga; Kimberly D Hieftje; Lynn E Fiellin; E Jennifer Edelman; Marjorie S Rosenthal; Lindsay R Duncan
Journal:  Health Educ Res       Date:  2014-01-21

6.  Framing recommendations to promote prevention behaviors among people at high risk: A simulation study of responses to melanoma genetic test reporting.

Authors:  Jennifer M Taber; Lisa G Aspinwall
Journal:  J Genet Couns       Date:  2015-01-14       Impact factor: 2.537

7.  Message framing strategies to increase influenza immunization uptake among pregnant African American women.

Authors:  Heather A Marsh; Fauzia Malik; Eve Shapiro; Saad B Omer; Paula M Frew
Journal:  Matern Child Health J       Date:  2014-09

8.  Perceived risk as a moderator of the effectiveness of framed HIV-test promotion messages among women: a randomized controlled trial.

Authors:  Shawnika J Hull
Journal:  Health Psychol       Date:  2011-07-18       Impact factor: 4.267

9.  Factors associated with maternal influenza immunization decision-making. Evidence of immunization history and message framing effects.

Authors:  Paula M Frew; Lauren E Owens; Diane S Saint-Victor; Samantha Benedict; Siyu Zhang; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2014-11-06       Impact factor: 3.452

10.  Does perceived risk influence the effects of message framing? A new investigation of a widely held notion.

Authors:  Jonathan Van 't Riet; Anthony D Cox; Dena Cox; Gregory D Zimet; Gert-Jan De Bruijn; Bas Van den Putte; Hein De Vries; Marieke Q Werrij; Robert A C Ruiter
Journal:  Psychol Health       Date:  2014-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.